Here's a list of the standard covered conditions: Cancer Life Threatening
Cancer Early Prostate Cancer (Partial) Ductal Breast Cancer (Partial) Superficial Malignant Melanoma (Partial) Benign Brain Tumour Stroke Heart Heart Attack Coronary Artery Bypass Surgery Heart Valve Replacement Aortic Surgery Angioplasty (Partial) Multiple Sclerosis Motor Neuron Disease Alzheimer's Disease Parkinson's Disease Aplastic Anemia Loss of -LSB-...]
Not exact matches
Blackmun stepped down
earlier this week to deal with
prostate cancer, though Raisman, several high - profile gymnasts and two U.S. Senators had been calling for his ouster for weeks.
Buffett has said that he remains in good health and his doctors never considered the
prostate cancer life - threatening because it was caught
early.
NEW YORK (360Dx)-- Biotech firm Berg continued its push into
cancer diagnostics with the presentation of several posters earlier this month at the annual meeting of the American Association for Cancer Research and the preparation of a forthcoming publication detailing an assay for distinguishing between prostate cancer and benign prostate hyperp
cancer diagnostics with the presentation of several posters
earlier this month at the annual meeting of the American Association for
Cancer Research and the preparation of a forthcoming publication detailing an assay for distinguishing between prostate cancer and benign prostate hyperp
Cancer Research and the preparation of a forthcoming publication detailing an assay for distinguishing between
prostate cancer and benign prostate hyperp
cancer and benign
prostate hyperplasia.
It has high hopes for approvals of
earlier use of Ibrance and the
prostate cancer drug Xtandi that would boost sales.
He was diagnosed as having
prostate cancer in the
early»90s (the
cancer is in remission) and underwent quintuple bypass surgery in July 2001, but is as fit as most men 20 years his junior.
Scientists have linked BPA to a growing list of ailments:
cancer, reproductive and cardiovascular system disorders (including damage to the
prostate gland, infertility and
early puberty), brain and neurological system dysfunctions, behavioral problems, diabetes and obesity.
But that was the unnerving conclusion of a draft report released last week by the National Toxicology Program, part of the National Institutes of Health, which said exposure to BPA may be linked to breast
cancer,
prostate cancer and
early puberty in girls.
And animal research has linked even low - level exposure to everything from female reproductive disorders,
early puberty,
early - stage breast and
prostate cancer, and decreased sperm count to attention and developmental problems.
Giuliani, who is a
prostate cancer survivor himself, assured Sliwa he'll «come out of this just fine» and also took the opportunity to remind men to get tested, even starting as
early as 10 years before the recommended age of 50.
(CNN)-- Connecticut Democrat Sen. Chris Dodd was released Saturday from Memorial Sloan - Kettering
Cancer Center after surgery to treat early stage prostate cancer, Dodd's office said in a stat
Cancer Center after surgery to treat
early stage
prostate cancer, Dodd's office said in a stat
cancer, Dodd's office said in a statement.
Dr Catherine Pickworth from
Cancer Research UK, said: «This early stage study adds to the growing evidence that some men with prostate cancer could benefit from being given PARP inhibitors alongside hormone deprivation trea
Cancer Research UK, said: «This
early stage study adds to the growing evidence that some men with
prostate cancer could benefit from being given PARP inhibitors alongside hormone deprivation trea
cancer could benefit from being given PARP inhibitors alongside hormone deprivation treatment.
An implant of genetically engineered skin cells has been designed to grow darker in colour when it detects
early breast,
prostate and colon
cancers
Shown here is an image of
early stage -
prostate cancer where the
cancer cells lack the PTEN and INPP4B genes.
A new screening tool for
prostate cancer, the
prostate - specific antigen test, enabled doctors to detect it
earlier in more men, and patients were flocking to hospitals for low doses of conventional photon radiation.
While
prostate cancer is relatively easy to treat in its
early stages, it is prone to metastasis and can quickly become deadly.
Several markers for dying from
prostate cancer exist, but whether these are markers for telling who is likely to die
early from any cause, and how their performance compares, is unknown.
«An estimated 220,000 men are expected to be newly diagnosed with
prostate cancer each year in the United States, and the majority will have
early - stage disease at low risk for recurrence,» Lee said.
«Targeting multiple biomarkers could potentially allow us to identify
prostate cancer at its
early stages as well as after metastasis in one scan.»
«This study's results can have practice changing implications on how future
prostate cancer trials are designed in terms of identifying the men for these studies who are at high risk for
early death due to ineffective initial treatment for their
prostate cancer,» stated Anthony Victor D'Amico, MD, PhD, chief, Genitourinary Radiation Oncology, Brigham and Women's Hospital and senior author of the study.
For
prostate cancer patients who have rising levels of PSA (a
cancer indicator) even after radical prostatectomy,
early treatment makes a difference.
Over the past year, some regional insurers have begun to concur, refusing to pick up the tab for
early treatment of
prostate cancer.
«Shorter, intensive radiation can be recommended in
early prostate cancer.»
Using data from a randomized trial of 206 men treated with either radiation or, radiation and six months of hormonal therapy, researchers compared
early markers of
prostate cancer death to identify men at risk of dying
early.
Most
early prostate cancers require male sex hormones, known as androgens, to grow.
«Patients diagnosed with
early - stage
prostate cancer — and that's the vast majority of patients with this disease — face many treatment options that are thought to be similarly efficacious,» said Ronald C. Chen, MD, MPH, UNC Lineberger member and associate professor in the UNC School of Medicine Department of Radiation Oncology.
«With further validation, this radiotracer could also potentially be used to perform targeted biopsies for precise tissue analysis, which could lead to
earlier, more appropriate treatment for
prostate cancer patients.»
Prostate cancer is highly curable, with a 94 percent 15 - year relative survival rate for
early stages.
For patients with
early - stage
cancer, this option avoids many of the side effects associated with removing the
prostate or irradiating the entire gland.
For
prostate cancer, the key reason for the fall in death rates is improved management and treatment, with a possible role played by screening and
early diagnosis.
Jake's
prostate cancer, diagnosed 16 years
earlier, was finally catching up with him.
For the study, UNC Lineberger researchers surveyed 1,141 men who were diagnosed with
early - stage
prostate cancer between January 2011 and June 2013.
We now need to find better ways of diagnosing aggressive
prostate cancers that need to be treated
early.»
If detected at
early stages the prognosis is quite favorable; however, aggressive forms of metastatic
prostate cancer spread primarily to the skeleton.
Edward Messing, the senior author of the study, says that PSA is capable of detecting the disease
earlier, which could, in theory lead to fewer deaths from
prostate cancer.
Cancer Research UK's hunt for finding early stages of aggressive prostate cancer is not
Cancer Research UK's hunt for finding
early stages of aggressive
prostate cancer is not
cancer is not over.
In 2009 the nongovernmental Institute of Medicine (IOM) released a list of 100 disorders, including lower back pain, atrial fibrillation, and
early prostate cancer, that it says require research analyzing which treatments work best for different groups of patients.
Earlier today, the U.S. Food and Drug Administration announced that it was giving the green light to Provenge, a treatment for advanced
prostate cancer that has spread to other parts of the body.
Early epidemiological studies suggested that men who ate diets rich in tomato products enjoyed lower than average rates of
prostate cancer, and lycopene was identified as the likely reason.
«New
early detection test for
prostate cancer.»
The five types of
cancers analyzed in this study have screening methods that allow for detection at an
early stage, though in some instances, debate remains over efficacy and appropriate use: mammography for breast
cancer, colonoscopy for colorectal
cancer, Pap smear and / or HPV test for cervical
cancer, spiral computed tomography or CT for lung
cancer, and PSA test for
prostate cancer.
«The androgen signaling cascade is important for understanding
early and late - stage
prostate cancer progression.
«Less
prostate cancer screening may delay treatment for
earlier onset
cancers: More advanced
cancers are being found in fewer needle biopsies, say investigators.»
«The
Prostate Health Index is a significant addition to our comprehensive menu of advanced clinical evidence ‐ based blood tests that aid in
early cancer detection.»
«New three - in - one blood test opens door to precision medicine for
prostate cancer: Test picks out men for treatment, detects
early signs of resistance and monitors
cancer's evolution over time.»
This assessment may represent a powerful biomarker to predict
cancer progression for men with
early - stage
prostate cancer.
It could in future allow the PARP inhibitor olaparib to become a standard treatment for advanced
prostate cancer, by targeting the drug at the men most likely to benefit, picking up
early signs that it might not be working, and monitoring for the later development of resistance.
Their analysis included 2,506 African American and 21,454 Caucasian patients diagnosed with
early (non-metastatic)
prostate cancer from 2004 to 2007 and treated within 12 months of diagnosis.
The study suggests that efforts are needed to reduce racial disparities in
prostate cancer care in order to provide
earlier treatment for African Americans.
Although Ribeiro's research into kidney fat is too new to have borne results, his
earlier work on
prostate cancer could hold some clues about the kidney -
cancer obesity paradox.